Tech & Pharma

Global Carbon Capture And Storage Institute Opens Office In Japan

The Global CCS Institute will establish an office in Japan to expand its involvement with some of the region’s leading capture technology developers.

September 6, 2011

Hitachi Group Makes Hitachi India Its Fifth Regional Headquarters

Hitachi, Ltd. announced this week that it has identified India as a fifth key management area.

September 6, 2011

Hatchtech Completes Treatment Phase Of DeOvo Phase IIb Trial For Head Lice

Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase IIb clinical study to confirm the efficacy of its novel head lice treatment DeOvo™.

September 4, 2011

Dr. Reddy’s Initiates Phase II Study With CETP Inhibitor, DRL-17822

Dr. Reddy’s Laboratories announced this week the initiation of a Phase II study of DRL-17822 in patients with diagnosis of type II dyslipidemia.

September 3, 2011

Sanofi Aventis & Multicare Ink Strategic Agreement In The Philippines

Sanofi-Aventis Philippines Inc. and Multicare Pharmaceuticals have entered into a marketing and distribution agreement.

September 3, 2011

Canada & Hitachi Sign R&D Agreement On Nuclear Medicine, Safer Nuclear Plants

Two memorandums of understanding have been signed between the Canadian Government of Saskatchewan and Hitachi companies for research into nuclear medicine and safer nuclear technologies.

September 2, 2011

Takeda’s TAK-385 In Phase II Trials For Endometriosis, Uterine Fibroids

Takeda Pharma announced today that it has initiated Phase II clinical trials of TAK-385 in Japan for the treatment of endometriosis and uterine fibroids.

August 29, 2011

Simcere Receives Chinese FDA Approval For Anti-Rheumatic Drug Iremod

The State Food and Drug Administration has approved Simcere Pharmaceutical Group’s new anti-rheumatic drug, Iremod, used to treat symptoms of active rheumatic arthritis.

August 28, 2011

Vasomedical Inc. To Acquire Life Enhancement Technology & Biox Instruments

Vasomedical, Inc. has signed an agreement to purchase Life Enhancement Technology Limited and Biox Instruments.

August 28, 2011

Lundbeck Launches Antidepressent Lexapro In Japan

Lexapro® – the most prescribed branded antidepressant in the world – has been launched in Japan by H. Lundbeck A/S and its partners, Mochiba and Mitsubishi Tanabe Pharma.

August 27, 2011